IGHA1 and non-small cell lung carcinoma: In survival analyses, enriched ARG, IGHA1, MMP14, PLAU, S100A8 and diminished HPGD in LUSC, as well as decreased SELENOP and FOLR2 in LUAD were all significantly correlated with a worse survival in NSCLC patients.